Rapport Therapeutics, Inc. (RAPP)
27.84
-0.83
(-2.90%)
USD |
NASDAQ |
Mar 13, 16:00
27.85
+0.01
(+0.04%)
After-Hours: 20:00
Rapport Therapeutics Total Assets (Quarterly) : 512.43M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bridgebio Oncology Therapeutics, Inc. | 449.08M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 233.89M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.78M |
| Shareholders Equity (Quarterly) | 484.65M |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 26.17 |
| Net Debt Paydown Yield | -0.18% |